Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

Female pattern hair loss does not significantly affect sexual dysfunction.

Finasteride may cause side effects; more research needed.

Finasteride use in young men with hair loss is linked to sexual dysfunction.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

Dutasteride safely promotes hair growth and reduces hair loss, with mild side effects.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

Treatments for enlarged prostate can cause problems with ejaculation, and less invasive options might preserve sexual function better.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Environmental factors and exposure to toxins may contribute to male infertility by affecting sperm and hormone function.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

The document suggests that finasteride may cause depression and suicidal thoughts, while prostate surgery does not harm sexual health.

Finasteride effectively stops hair loss in most patients, but concerns about rare sexual side effects exist.

Lower finasteride doses had more side effects; dutasteride caused back pain; more research needed on post-finasteride syndrome.

Hair restoration surgery has advanced, focusing on natural results and may improve further with new techniques and therapies.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.